Jean Pierre Sommadossi Atea Pharmaceuticals, Inc. (AVIR) insider trading activity

AVIR Quotes by TradingView

Jean Pierre Sommadossi is President, CEO, and Chairman of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 116,557 shares of AVIR, which is worth approximately $396,293. The most recent transaction as insider was on Feb 01, 2024, when has been sold 56,910 shares (Common Stock) at a price of $3.85 per share, resulting in proceeds of $219,103. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 117K
0% 3M change
n/a 12M change
Total Value Held $396,293

Jean-Pierre Sommadossi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
SELL
Open market or private sale
$219,103 $3.85 p/Share
56,910 Reduced 32.81%
116,557 Common Stock
Jan 31 2024
BUY
Exercise of conversion of derivative security
-
173,467 Added 50.0%
173,467 Common Stock

Also insider at

KZR
Kezar Life Sciences, Inc. Healthcare
Director
ABGI
ABG Acquisition Corp. I Financial Services
Director
JS

Jean Pierre Sommadossi

President, CEO, and Chairman
Boston, MA

Track Institutional and Insider Activities on AVIR

Follow Atea Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVIR shares.

Notify only if

Insider Trading

Get notified when an Atea Pharmaceuticals, Inc. insider buys or sells AVIR shares.

Notify only if

News

Receive news related to Atea Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVIR